Abivax unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human immunodeficiency virus (HIV). Credit: Shutterstock.
Cancer Research UK Clinical Trials Unit at the University of Birmingham started a Phase I trial for leukaemia. Credit: Cancer Research UK.
A healthy volunteer received an IV infusion of mAb114. Credit: NIAID.